TANG CAPITAL MANAGEMENT LLC

USReporting entityDirector

Transactions

133

Issuers

Buys / Sells

108/16

Last tx

18 Sept 2024

FrançaisSign in Try free 14d

Insider

TANG CAPITAL MANAGEMENT LLC

USReporting entityDirector

Transactions

133

Issuers

Buys / Sells

108/16

Last tx

18 Sept 2024

Behaviour

6 purchases reported after at least 12 months of silence — most recent on 13 Mar 2023.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Odonate Therapeutics, Inc.	12,767,435	reported	19 Nov 2021	tx 24+148,768−2,747,131
NEOSE TECHNOLOGIES INC	10,406,642	reported	29 Sept 2008	tx 5+586,459
LA JOLLA PHARMACEUTICAL CO	10,005,490	reported	01 Jun 2021	tx 27+964,575
HERON THERAPEUTICS, INC. /DE/	5,830,215	reported	12 Sept 2018	tx 13+83,173,190−4,188,639

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.

1 month

+5.8%

Sample9

Win rate (≥5%)56%

Hit rate (>0)56%

3 months

−8.0%

Sample7

Win rate (≥5%)43%

Hit rate (>0)43%

6 months

−11.6%

Sample7

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
16 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	50,416	12.74 USD
17 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	40,000	15.33 USD
18 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	32,000	17.21 USD
11 Oct 2023	PURCHASE	Rain Therapeutics Inc.	74,812	0.97 USD
12 Oct 2023	PURCHASE	Rain Therapeutics Inc.	25,188	0.98 USD
13 Oct 2023	PURCHASE	Rain Therapeutics Inc.	84,145	0.99 USD
13 Oct 2023	PURCHASE	Rain Therapeutics Inc.	47,486	0.99 USD
12 Oct 2023	PURCHASE	Rain Therapeutics Inc.	52,514	0.98 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	2,016	1.08 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	5,930	1.06 USD
31 May 2023	PURCHASE	Rain Therapeutics Inc.	161,180	1.08 USD
31 May 2023	PURCHASE	Rain Therapeutics Inc.	5,000	1.10 USD
01 Jun 2023	PURCHASE	Rain Therapeutics Inc.	92,984	1.09 USD
01 Jun 2023	PURCHASE	Rain Therapeutics Inc.	240,341	1.12 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	347,932	1.05 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	200,000	1.00 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	32,890	1.06 USD
13 Mar 2023	PURCHASE	Jounce Therapeutics, Inc.	65,701	0.99 USD	first after silence
14 Mar 2023	PURCHASE	Jounce Therapeutics, Inc.	20,286	1.02 USD
18 Nov 2021	SALE	Odonate Therapeutics, Inc.	500,000	1.88 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	468,849	2.66 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	31,151	1.99 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	500,000	2.02 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	287,577	2.20 USD
18 Nov 2021	SALE	Odonate Therapeutics, Inc.	212,423	1.97 USD

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Odonate Therapeutics, Inc.	12,767,435	reported	19 Nov 2021	tx 24+148,768−2,747,131
NEOSE TECHNOLOGIES INC	10,406,642	reported	29 Sept 2008	tx 5+586,459
LA JOLLA PHARMACEUTICAL CO	10,005,490	reported	01 Jun 2021	tx 27+964,575
HERON THERAPEUTICS, INC. /DE/	5,830,215	reported	12 Sept 2018	tx 13+83,173,190−4,188,639

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.

1 month

+5.8%

Sample9

Win rate (≥5%)56%

Hit rate (>0)56%

3 months

−8.0%

Sample7

Win rate (≥5%)43%

Hit rate (>0)43%

6 months

−11.6%

Sample7

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
16 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	50,416	12.74 USD
17 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	40,000	15.33 USD
18 Sept 2024	PURCHASE	Singular Genomics Systems, Inc.	32,000	17.21 USD
11 Oct 2023	PURCHASE	Rain Therapeutics Inc.	74,812	0.97 USD
12 Oct 2023	PURCHASE	Rain Therapeutics Inc.	25,188	0.98 USD
13 Oct 2023	PURCHASE	Rain Therapeutics Inc.	84,145	0.99 USD
13 Oct 2023	PURCHASE	Rain Therapeutics Inc.	47,486	0.99 USD
12 Oct 2023	PURCHASE	Rain Therapeutics Inc.	52,514	0.98 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	2,016	1.08 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	5,930	1.06 USD
31 May 2023	PURCHASE	Rain Therapeutics Inc.	161,180	1.08 USD
31 May 2023	PURCHASE	Rain Therapeutics Inc.	5,000	1.10 USD
01 Jun 2023	PURCHASE	Rain Therapeutics Inc.	92,984	1.09 USD
01 Jun 2023	PURCHASE	Rain Therapeutics Inc.	240,341	1.12 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	347,932	1.05 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	200,000	1.00 USD
30 May 2023	PURCHASE	Rain Therapeutics Inc.	32,890	1.06 USD
13 Mar 2023	PURCHASE	Jounce Therapeutics, Inc.	65,701	0.99 USD	first after silence
14 Mar 2023	PURCHASE	Jounce Therapeutics, Inc.	20,286	1.02 USD
18 Nov 2021	SALE	Odonate Therapeutics, Inc.	500,000	1.88 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	468,849	2.66 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	31,151	1.99 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	500,000	2.02 USD
17 Nov 2021	SALE	Odonate Therapeutics, Inc.	287,577	2.20 USD
18 Nov 2021	SALE	Odonate Therapeutics, Inc.	212,423	1.97 USD